Milestone Pharmaceuticals... (MIST)
NASDAQ: MIST
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.66
-2.06%
After-hours: Aug 15, 2025, 06:01 PM EDT
Milestone Pharmaceuticals Fail-to-Deliver
Total FTD Shares
507
Below Average
FTD / Avg. Volume
0.04%
Low Impact
1-Year Change
-81.3%
Negative Trend
FTD Chart
As of Jul 9, 2025,
Milestone Pharmaceuticals Inc. has
507
shares failed to deliver, representing 0.04%
of the average daily volume of
1,404,077
shares. Over the past year, the monthly average FTD is
7,296
shares, with the current level 93% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 09, 2025 | 2.4 | 507 | -37.56% |
| Jun 18, 2025 | 1.72 | 812 | -95.18% |
| May 20, 2025 | 1.39 | 16.84K | +77.34% |
| Apr 30, 2025 | 1.32 | 9.5K | -88.22% |
| Mar 31, 2025 | 0.8001 | 80.66K | +2248.15% |
| Feb 14, 2025 | 2.27 | 3.44K | +2425.74% |
| Dec 30, 2024 | 2.25 | 136 | -98.28% |
| Nov 21, 2024 | 1.85 | 7.93K | -78.64% |
| Oct 31, 2024 | 1.45 | 37.11K | +100189.19% |
| Sep 30, 2024 | 1.52 | 37 | -98.71% |
| Aug 28, 2024 | 1.45 | 2.87K | +2465.18% |
| Jul 29, 2024 | 1.48 | 112 | -98.75% |
| Jun 27, 2024 | 1.29 | 8.96K | +1613.38% |
| May 31, 2024 | 1.5 | 523 | -82.09% |
| Apr 29, 2024 | 1.57 | 2.92K | +9.36% |
| Mar 26, 2024 | 1.81 | 2.67K | -28.30% |
| Feb 28, 2024 | 2.13 | 3.72K | -51.13% |
| Jan 31, 2024 | 1.6 | 7.62K | +1448.78% |
| Dec 29, 2023 | 1.67 | 492 | -73.11% |
| Nov 30, 2023 | 3.34 | 1.83K | +1425.00% |
| Oct 25, 2023 | 2.41 | 120 | -94.74% |
| Sep 29, 2023 | 3.1 | 2.28K | +242.79% |
| Aug 14, 2023 | 3.13 | 666 | +174.07% |
| Jul 31, 2023 | 3.23 | 243 | -76.97% |
| Jun 16, 2023 | 3.5 | 1.05K | +531.74% |
| May 31, 2023 | 3.94 | 167 | -79.43% |
| Apr 28, 2023 | 3.63 | 812 | +99.51% |
| Mar 31, 2023 | 3.94 | 407 | +41.32% |
| Feb 27, 2023 | 3.19 | 288 | -99.51% |
| Jan 30, 2023 | 3.49 | 58.85K | n/a |